At the IGTP TODAY

News

- Research

In search of biomarkers to detect patients with latent Plasmodium vivax infections

A study reveals the presence of proteins from hypnozoites, the latent phase of the parasite, in circulating extracellular vesicles. Proteins derived from the latent liver stage of Plasmodium vivax can be detected in small extracellular vesicles that circulate in blood, according to a study led by Hernando del Portillo, ICREA Research Professor at the IGTP and ISGlobal.  The results pave the way for identifying patients with asymptomatic infections, an essential requirement to stop parasite transmission. 

- Research

Researchers describe the cause and neurodegenerative mechanisms of a new sub-type of ataxia

The Neurogenetics Research Group at the Germans Trias i Pujol Research Group, led by Dr Antoni Matilla has found the mutation and described the molecular mechanism that causes the sub-type of ataxia SCA37, which they first described in 2013.  This find means that all the families with this alteration can be diagnosed before symptoms appear and that carriers can receive genetic counselling.  It is also the first step on developing personalized therapies.

- Research

The DiabetesCero (Diabetes Zero) Foundation has got the European Parliament talking about Diabetes Type 1

From Vilanova i la Geltrú to Brussels by bicycle.  This challenge was accepted by the father of a boy with diabetes type 1 (DT1) and member of the charity DiabetesCero, and on the way he managed get Euro MPs interested in the disease.  His amazing journey has produced a meeting to discuss the DT1 on 21-22 June; Dr Marta Vives-Pi, Group Leader of the Immunology of Diabetes Group of the IGTP was there.

- Research

20,000 healthy people from across Catalonia participate in a macro research project to better understand the risk factors for the most common diseases

The Genomes for Life Project (GCAT) in collaboration with the Blood and Tissue Bank (BST) has collected genetic, health and lifestyle information from 20,000 people in the Catalan area.  This April the first phase, the collection of samples and data, has closed and the second follow-up phase has got underway, this will continue for at least 20 years.  With all the data collected, the GCAT Project will be able to evaluate the role of genetic and epidemiological factors in the development of the main chronic diseases in Catalonia.